Yankcom Partnership Standard Biotools Inc. Transaction History
Yankcom Partnership
- $235 Billion
- Q4 2025
A detailed history of Yankcom Partnership transactions in Standard Biotools Inc. stock. As of the latest transaction made, Yankcom Partnership holds 94 shares of LAB stock, worth $116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94Holding current value
$116% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
163Shares Held
283MCall Options Held
59.7KPut Options Held
18.7K-
Casdin Capital, LLC New York, NY77.6MShares$96.2 Million13.74% of portfolio
-
Viking Global Investors LP58.7MShares$72.7 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$21.4 Million0.0% of portfolio
-
Mak Capital One LLC New York, NY15.9MShares$19.8 Million3.18% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $97.5M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...